L’amélioration de la performance et de la structure cardiaque par la moxonidine chez les SHR est accompagnée d’une diminution des cytokines, de la MAPK p38 et de l’Akt

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Unknown venue

• Publication date

  2011-05-05

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Cardiac Fibroblasts

  2012influential reference
• MAPK-Activated Protein Kinase-2 in Cardiac Hypertrophy and Cyclooxygenase-2 Regulation in Heart

  2010influential reference
• Interleukin 6 Mediates Myocardial Fibrosis, Concentric Hypertrophy, and Diastolic Dysfunction in Rats

  2010influential reference
• Molecular targets and regulators of cardiac hypertrophy.

  2010influential reference
• Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale.

  2010cited by this paper
• Plasma visfatin concentrations after a lifestyle intervention were directly associated with inflammatory markers.

  2009cited by this paper
• Mammalian Target of Rapamycin Is a Critical Regulator of Cardiac Hypertrophy in Spontaneously Hypertensive Rats

  2009cited by this paper
• PARP inhibition delays transition of hypertensive cardiopathy to heart failure in spontaneously hypertensive rats.

  2009influential reference
• Cardiac Mast Cells Mediate Left Ventricular Fibrosis in the Hypertensive Rat Heart

  2009cited by this paper
• Divergent Tumor Necrosis Factor Receptor-Related Remodeling Responses in Heart Failure: Role of Nuclear Factor-&kgr;B and Inflammatory Activation

  2009cited by this paper
• Chronic beta-adrenergic activation-induced left ventricular systolic dysfunction is associated with systemic release of TNF-alpha and IL-1-beta in rats.

  2009influential reference
• Small GTP-binding proteins and their regulators in cardiac hypertrophy.

  2008cited by this paper
• Hypertension in aortic valve stenosis--a Trojan horse.

  2008cited by this paper
• Coronary calcium scoring and cardiovascular risk: the SHAPE of things to come.

  2008cited by this paper
• Recent advances in selective alpha1-adrenoreceptor antagonists as antihypertensive agents.

  2008influential reference
• Effect of Antecedent Hypertension and Follow-Up Blood Pressure on Outcomes After High-Risk Myocardial Infarction

  2008cited by this paper
• Control of left ventricular mass by moxonidine involves reduced DNA synthesis and enhanced DNA fragmentation

  2008influential reference
• Mechanism of TNFalpha-induced IL-1alpha, IL-1beta and IL-6 expression in human cardiac fibroblasts: effects of statins and thiazolidinediones.

  2007cited by this paper
• IL-1beta stimulates rat cardiac fibroblast migration via MAP kinase pathways.

  2007cited by this paper
• p38 and ERK1/2 MAPKs mediate the interplay of TNF-alpha and IL-10 in regulating oxidative stress and cardiac myocyte apoptosis.

  2007cited by this paper
• Effects of Normal Blood Pressure, Prehypertension, and Hypertension on Coronary Microvascular Function

  2007cited by this paper
• Loss of myocardial LIF receptor in experimental heart failure reduces cardiotrophin-1 cytoprotection. A role for neurohumoral agonists?

  2007cited by this paper
• [Different expressions of inflammatory cytokines in two types of cardiac hypertrophy in rats].

  2007cited by this paper
• Relationship Between Central Sympathetic Drive and Magnetic Resonance Imaging–Determined Left Ventricular Mass in Essential Hypertension

  2007cited by this paper
• TNF provokes cardiomyocyte apoptosis and cardiac remodeling through activation of multiple cell death pathways.

  2007cited by this paper
• Albuminuria and chronic kidney disease in association with the metabolic syndrome.

  2007cited by this paper
• Survival pathways in hypertrophy and heart failure: The gp130-STAT3 axis

  2007influential reference
• Cross-link breakers as a new therapeutic approach to cardiovascular disease.

  2007cited by this paper
• Exercise Capacity and Blood Pressure Associations With Left Ventricular Mass in Prehypertensive Individuals

  2007cited by this paper
• The intracellular renin-angiotensin system: a new paradigm.

  2007cited by this paper
• Tumor Necrosis Factor- (cid:1) Mediates Cardiac Remodeling and Ventricular Dysfunction After Pressure Overload State Molecular Cardiology

  2007cited by this paper
• Cytokines regulate matrix metalloproteinases and migration in cardiac fibroblasts.

  2007influential reference
• The Renin-Angiotensin Aldosterone System: Pathophysiological Role and Pharmacologic Inhibition

  2007cited by this paper
• Effects of p38 MAPK Inhibitor on Angiotensin II-Dependent Hypertension, Organ Damage, and Superoxide Anion Production

  2007cited by this paper
• Nitric oxide-dependent and -independent mechanisms are involved in TNF-alpha -induced depression of cardiac myocyte contractility.

  2007cited by this paper
• Cardiac GPCRs: GPCR signaling in healthy and failing hearts.

  2007influential reference
• Tumor necrosis factor-alpha is toxic via receptor 1 and protective via receptor 2 in a murine model of myocardial infarction.

  2007cited by this paper
• Mechanisms of sympathetic activation in obesity-related hypertension.

  2006cited by this paper
• Risk of death associated with nesiritide in patients with acutely decompensated heart failure.

  2006cited by this paper
• Small Heat-Shock Protein Hsp20 Attenuates &bgr;-Agonist–Mediated Cardiac Remodeling Through Apoptosis Signal–Regulating Kinase 1

  2006cited by this paper
• The sympathetic control of blood pressure

  2006cited by this paper
• Blood pressure usually considered normal is associated with an elevated risk of cardiovascular disease.

  2006cited by this paper
• Systolic and diastolic heart failure in the community.

  2006cited by this paper
• JAK/STAT/SOCS SIGNALING CIRCUITS AND ASSOCIATED CYTOKINE-MEDIATED INFLAMMATION AND HYPERTROPHY IN THE HEART

  2006cited by this paper
• p38 MAP kinase activity is correlated with angiotensin II type 1 receptor blocker-induced left ventricular reverse remodeling in spontaneously hypertensive heart failure rats.

  2006influential reference
• The latest generation of beta-blockers: New pharmacologic properties

  2006cited by this paper
• Beta-adrenergic receptors signaling and heart failure in mice, rabbits and humans.

  2006cited by this paper
• Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database.

  2006cited by this paper
• Coronary atherosclerosis can regress with very intensive statin therapy.

  2006cited by this paper
• Akt3 overexpression in the heart results in progression from adaptive to maladaptive hypertrophy.

  2005influential reference
• Concurrent opposite effects of trichostatin A, an inhibitor of histone deacetylases, on expression of alpha-MHC and cardiac tubulins: implication for gain in cardiac muscle contractility.

  2005cited by this paper
• Regulation of therapeutic apoptosis: a potential target in controlling hypertensive organ damage.

  2005cited by this paper
• Urinary responses to acute moxonidine are inhibited by natriuretic peptide receptor antagonist

  2005cited by this paper
• A role for T lymphocytes in mediating cardiac diastolic function.

  2005cited by this paper
• Evaluation of Concentric Left Ventricular Geometry in Humans: Evidence for Age-Related Systematic Underestimation

  2005cited by this paper
• &agr;-Adrenergic Receptor–Stimulated Hypertrophy in Adult Rat Ventricular Myocytes Is Mediated via Thioredoxin-1–Sensitive Oxidative Modification of Thiols on Ras

  2005cited by this paper
• Recent progress in signal transduction research of the angiotensin II type-1 receptor: protein kinases, vascular dysfunction and structural requirement.

  2005cited by this paper
• C-type natriuretic peptide, a novel antifibrotic and antihypertrophic agent, prevents cardiac remodeling after myocardial infarction.

  2005cited by this paper
• Cardiac-Specific Overexpression of Diacylglycerol Kinase &zgr; Prevents Gq Protein-Coupled Receptor Agonist-Induced Cardiac Hypertrophy in Transgenic Mice

  2005cited by this paper
• Asymptomatic Left Ventricular Systolic Dysfunction in Essential Hypertension: Prevalence, Determinants, and Prognostic Value

  2005cited by this paper
• The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease.

  2004cited by this paper
• Association of inappropriate left ventricular mass with systolic and diastolic dysfunction: the HyperGEN study.

  2004cited by this paper
• Ras, PI3-kinase and mTOR signaling in cardiac hypertrophy.

  2004cited by this paper
• Targeted Activation of c-Jun N-terminal Kinase in Vivo Induces Restrictive Cardiomyopathy and Conduction Defects*[boxs]

  2004cited by this paper
• Imidazoline Receptors but Not α2-Adrenoceptors Are Regulated in Spontaneously Hypertensive Rat Heart by Chronic Moxonidine Treatment

  2004cited by this paper
• Rilmenidine sympatholytic activity preserves mental stress, orthostatic sympathetic responses and adrenaline secretion

  2004cited by this paper
• Activation of adenosine receptors inhibits tumor necrosis factor-alpha release by decreasing TNF-alpha mRNA stability and p38 activity.

  2004cited by this paper
• Involvement of the Serotonin 5-HT2B Receptor in Cardiac Hypertrophy Linked to Sympathetic Stimulation: Control of Interleukin-6, Interleukin-1&bgr;, and Tumor Necrosis Factor-&agr; Cytokine Production by Ventricular Fibroblasts

  2004cited by this paper
• Hypertensive Myocardial Fibrosis and Diastolic Dysfunction: Another Model of Inflammation?

  2004cited by this paper
• Clinical practice. Diastolic heart failure.

  2004cited by this paper
• Cardiac myocyte apoptosis provokes adverse cardiac remodeling in transgenic mice with targeted TNF overexpression.

  2004cited by this paper
• Pharmacological therapy can increase capillary density in post-infarction remodeled rat hearts.

  2004cited by this paper
• Regulation of norepinephrine-induced proliferation in cardiac fibroblasts by interleukin-6 and p42/p44 mitogen activated protein kinase

  2004cited by this paper
• Network integration of the adrenergic system in cardiac hypertrophy.

  2004cited by this paper
• Tumor necrosis factor alpha induces human atrial myofibroblast proliferation, invasion and MMP-9 secretion: inhibition by simvastatin.

  2004cited by this paper
• Sympathetic Augmentation in Hypertension: Role of Nerve Firing, Norepinephrine Reuptake, and Angiotensin Neuromodulation

  2004cited by this paper
• Moxonidine in the treatment of overweight and obese patients with the metabolic syndrome: a postmarketing surveillance study

  2004cited by this paper
• ST Segment Depression Criteria and the Prevalence of Silent Cardiac Ischemia in Hypertensives

  2003cited by this paper
• Morphological and functional changes in cardiac myocytes isolated from mice overexpressing TNF-alpha.

  2003cited by this paper
• Relationships between ambulatory white coat effect and left ventricular mass in arterial hypertension.

  2003cited by this paper
• β‐adrenergic receptor‐mediated DNA synthesis in neonatal rat cardiac fibroblasts proceeds via a phosphatidylinositol 3‐kinase dependent pathway refractory to the antiproliferative action of cyclic AMP

  2003cited by this paper
• Therapeutic inhibition of tumour necrosis factor α in patients with heart failure: cooling an inflamed heart

  2003cited by this paper
• Chronic beta2-adrenergic receptor stimulation increases proliferation of human cardiac fibroblasts via an autocrine mechanism.

  2003cited by this paper
• Tritium labelling and characterization of the potent imidazoline I1 receptor antagonist [5,7-3H] (+/-)-efaroxan at high specific activity.

  2003cited by this paper
• Diagnosing secondary hypertension.

  2003cited by this paper
• Myocyte death, growth, and regeneration in cardiac hypertrophy and failure.

  2003cited by this paper
• Phosphoinositide 3-kinase gamma-deficient mice are protected from isoproterenol-induced heart failure.

  2003cited by this paper
• Inflammatory Markers and Risk of Heart Failure in Elderly Subjects Without Prior Myocardial Infarction: The Framingham Heart Study

  2003cited by this paper
• Interleukin-6 Family of Cytokines Mediates Isoproterenol-induced Delayed STAT3 Activation in Mouse Heart*

  2003cited by this paper
• Atrial Fibrillation in Hypertension: Predictors and Outcome

  2003cited by this paper
• Relation Between Cardiac Sympathetic Activity and Hypertensive Left Ventricular Hypertrophy

  2003cited by this paper
• Phenotyping hypertrophy: eschew obfuscation.

  2003cited by this paper
• Norepinephrine-induced interleukin-6 increase in rat hearts: differential signal transduction in myocytes and non-myocytes

  2003cited by this paper
• [Expression of beta2-adrenergic receptor and its effect on the proliferation of neonatal rat cardiac fibroblasts].

  2003cited by this paper
• Secretion of IL-6, IL-11 and LIF by human cardiomyocytes in primary culture.

  2002cited by this paper
• MEKK1 is essential for cardiac hypertrophy and dysfunction induced by Gq

  2002cited by this paper
• Using a gene-switch transgenic approach to dissect distinct roles of MAP kinases in heart failure.

  2002cited by this paper
• Cardiotrophin-1 Stimulation of Cardiac Fibroblast Growth: Roles for Glycoprotein 130/Leukemia Inhibitory Factor Receptor and the Endothelin Type A Receptor

  2002cited by this paper
• Load-Dependent and -Independent Regulation of Proinflammatory Cytokine and Cytokine Receptor Gene Expression in the Adult Mammalian Heart

  2002cited by this paper
• Imidazoline Receptors in the Heart: Characterization, Distribution, and Regulation

  2002influential reference

• No citing papers are available for this paper.